FSH

DRUG7 trials

Sponsors

Organon and Co, Vietnam National University, Cairo University, Mansoura University, Kaohsiung Veterans General Hospital.

Conditions

IVFIn Vitro FertilizationInfertilityNeonatesPregnancyUnrecognized Condition

Phase 3

Corifollitropin Alfa in Participants Undergoing Repeated Controlled Ovarian Stimulation (COS) Cycles Using a Multiple Dose Gonadatropin Releasing Hormone (GnRH) Antagonist Protocol (Study 38825)(P05714)

CompletedNCT00696878

Organon and CoIn Vitro Fertilization

Start: 2006-09-26End: 2009-05-15Updated: 2024-06-18

Comparison Between Letrozole and Urinary Purified FSH in Women With Clomiphene Citrate Resistant Polycystic Ovarian Syndrome.

CompletedNCT02304107

Cairo UniversityInfertility

Start: 2013-05-31End: 2015-01-31Updated: 2016-07-06

Comparison Between Laparoscopic Ovarian Diathermy and Urinary Purified FSH in Women With Clomiphene Citrate Resistant Polycystic Ovarian Syndrome.

Cairo UniversityInfertility

Start: 2014-11-30Target: 210Updated: 2017-01-23

Phase 4

Anti-Mullerian Hormone (AMH) Versus Antral Follicle Count (AFC) Guided rFSH Dosing Study

CompletedNCT01783301

Vietnam National UniversityInfertility

Start: 2011-10-31End: 2012-12-31Updated: 2013-02-04

FSH Followed by HMG vs FSH Plus HMG in IVF

Mansoura UniversityIVF

Start: 2020-06-30End: 2022-08-31Target: 530Updated: 2020-06-09

Unknown Phase

Pregnancy and Neonatal Follow-up of Ongoing Pregnancies Established in Clinical Trial P05714 (Care Program)(P05715)

CompletedNCT00702234

Organon and CoNeonates, Pregnancy

Start: 2007-02-15End: 2010-01-15Updated: 2024-09-05

Effects of LH and FSH on Metabolic Regulation in Cumulus Cells

RecruitingNCT06803199

Kaohsiung Veterans General Hospital.Unrecognized Condition

Start: 2024-12-01End: 2027-12-31Target: 60Updated: 2025-01-31

Related Papers

Cost effectiveness of letrozole and purified urinary FSH in treating women with clomiphene citrate-resistant polycystic ovarian syndrome: a randomized controlled trial

Human Fertility2016-11-0811 citations

Prediction of Ovarian Hyperstimulation Syndrome in Patients Treated with Corifollitropin alfa or rFSH in a GnRH Antagonist Protocol

PLoS ONE2016-03-0792 citations

Intercycle variability of the ovarian response in patients undergoing repeated stimulation with corifollitropin alfa in a gonadotropin-releasing hormone antagonist protocol.

2015-07-1522 citations

Repeated ovarian stimulation with corifollitropin alfa in patients in a GnRH antagonist protocol: no concern for immunogenicity.

2011-05-2725 citations